Not for distribution in the U.S. or to U.S. Newswires
VANCOUVER, British Columbia, Aug. 09, 2018 (GLOBE NEWSWIRE) -- BlissCo Cannabis Corp. (CSE: BLIS) (FRA: GQ4B), (“BlissCo”) or the (“Company”) is pleased to announce that the company has added Shannon Khan to its team to serve as Patient Care and Call Center Lead.
Ms. Khan is a Licensed Practical Nurse who has served as a leader in the Dr. Bernstein Diet and Health Clinics. She spent over six years as the clinic and regional manager at multiple Dr. Bernstein clinics in Calgary and Vancouver where she led teams of up to 20.
“We are pleased to welcome Ms. Khan to our team. High-quality patient care is a top priority for BlissCo and our primary focus in Canada is the medical cannabis market. Her experience with a national clinic such as Dr. Bernstein’s Diet and Health Clinics will be a strong asset to our team as we focus on patient acquisition and retention,” said Damian Kettlewell, CEO of BlissCo Cannabis Corp.
BlissCo’s telemedicine app is planned to launch in October, with the service being delivered in partnership with leading e-commerce provider, Namaste Technologies (TSXV: N).
About BlissCo Cannabis Corp.
BlissCo Cannabis Corp. (CSE: BLIS) (FRA: GQ4B) is an ACMPR licensed producer and future distributor of ultra-premium cannabis. The company sits at the heart of an international ecosystem and is focused on the success of its domestic and global partnerships.
BlissCo leverages the latest technology and is continuously developing its network of top-tier industry experts to drive the success of its brand and channels, moving premium Canadian cannabis to local and international markets.
BlissCo is backed by an experienced team that is deeply in tune and integrated with industry partners and BlissCo's future patients and customers.
Learn more: BlissCo.com
On Behalf of the Board of Directors
BLISSCO CANNABIS CORP.
Damian Kettlewell, CEO, Founder & Chair
For further information please contact:
Christina, Investor Relations
1-604-723-7480
christina.rao@blissco.com
Cautionary Statement
This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.
The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.